Iqiniso Mayelana Nokuntuleka Kwamavithamini D ne-COPD

Ukuntuleka kweVithamini D kuvame kakhulu kubantu abane- COPD , okwandisa ukusabalala nokuqina kwesifo. Sekuyiminyaka, ucwaningo luye lwahlola ubudlelwane phakathi kokuntuleka kwe-vitamin D ne-COPD ngomzamo wokuxhuma amachashazi futhi ngandlela-thile ukuxhumanisa lezi zinto ndawonye. Kuze kube manje, abukho ubufakazi obukhona bokusekela ukuthi ukutholakala kwe-vitamin D kuhlobene nenengozi eyanda kakhulu ye-COPD noma ukukhula kwe- COPD ekukhuphukeni.

Kodwa, lokho akusho ukuthi i-vitamin D, njenge-supplement, ayibalulekile. Ake sihlole lobu buhlobo kancane kancane.

Ukubaluleka kwamavithamini D

I-Vitamin D yinto engokwemvelo eyenziwa yizidumbu zethu ekuphenduleni ukukhanya kwelanga. Ukubaluleka kwe-vitamin D kuqala esibelethweni futhi kuqhubeka yonke impilo yethu. Indima yayo eyinhloko ukusiza imizimba yethu ithole i-calcium ekudleni esikudlayo. Njenge-calcium, kubalulekile ekutheni ukukhula nokuthuthukiswa. Ngaphandle kwe-vitamin D, izidumbu zethu ngeke zikwazi ukuthola i-calcium, ezoshiya amathambo ethu ahlukumezekile, abuthakathaka futhi athambekele ekuqhekekeni.

Izinhlobonhlobo ezihambisana nobunzima be-Vitamin D ne-COPD

Ukuntuleka kwe-Vitamin D kuchazwa ngokuthi kunezinga le-serum lama-25-hydroxyvitamin D angaphansi kuka-20 ng / ml. Abantu abane-COPD, abangenayo i-Vitamin D, banamathuba amaningi

Ukutholakala kwe-Vitamin D nokukhushulwa kwe-COPD

Ucwaningo luye lwathola ukuthi iziguli eziphezulu ze-vitamin D ezisezingeni eliphezulu lezakhi ze-COPD ezinezinga elilinganiselwe lokuntuleka kwe-vitamin D alinciphisi ukukhubazeka kwe-COPD. Ukwengezwa kungase kuncishiswe ukukhushulwa kweziguli ezinezinkinga ezinkulu zevithamini D.

Ngenxa yokuthi ukuntuleka kweVithamini D kuhlotshaniswa namazinga aphezulu okufa kwabantu ebhodini, ochwepheshe abaningi bakholelwa ukuthi i-Vitamin D ukwesekwa yindlela ebalulekile, engabizi kahle yokulawula ukuvimbela izifo.

Ngaphezu kwalokho, ucwaningo lubonisa ukuthi uketshezi lwe-calcium ne-vitamin D ezigulini ze-COPD ezingenalutho kulawa mavithamini zinganciphisa ingozi yokuhlukana okuhlobene nokwehla kwesifo se-osteoporosis. Ukwengezwa kungasiza ekunciphiseni ukuhlukunyezwa okuhlobene ne-COPD nokuvimbela umsebenzi wamaphaphu kusukela ekunciphiseni nakakhulu.

Ukuntuleka kwe-Vitamin D kuhlotshaniswa nokusebenza kakhudlwana kwamaphaphu kanye nokusebenza okusheshayo kwamapayipi ekunciphiseni kwabokubhema besikhathi eside. Ukwengezwa nge-vitamin D kungasiza ukuvikela amaphaphu emiphumeleni eyingozi yokubhema.

Izinzuzo zoNgezelelo

Ungakanani Uvithamini D Okufanele Uwathathe?

Ngokusho kweVitamin D Council, amazinga e-vitamin D angaphezu kuka 30-40 ng / mL (75-100 nmol / L) anganciphisa ingozi yeCOPD.

Ukuze kufinyelele kula mazinga, abantu abaningi badinga ukuthatha izinyunithi zamazwe angama-1000-5000 (IU) (25-125 mcg) ngosuku lwe-vitamin D3, uhlobo olusebenzayo lwevithamini D olukhiqizwa ngaphansi kwesikhumba. Kodwa-ke, baphinde bagcizelele ukuthi, ngoba kukhona ukuhlukahluka okukhulu komuntu nomuntu, isilinganiso esifanele kufanele sinqunywe ngokulinganisa amazinga wegazi legciwane lesiguli segciwane lesandulela ngculazi ngaphambili, kanye nezinyanga ezimbalwa emva kwalokho, ukuthatha izithako ezenziwe nge-vitamin D3 noma ukwanda kwe-UVB.

QAPHELA: Ngaphambi kokuba uqale ukwengeza ukudla kwakho nge-vitamin D, kungcono ukuhlola nomhlinzeki wakho wezempilo mayelana nokuthi yikuphi okungeziweko nomthamo okulungile kuwe.

Imithombo:

I-American Thoracic Society (2011, Meyi 15). I-Vitamin D ithuthukisa imiphumela yokuzivocavoca ezigulini ezine-COPD. IsayensiIsiSayensi.

UJanssens W, Mathieu C, Boonen S, i-Decramer M. Vitamin D kanye nesifo esingapheliyo se-pulmonary: umjikelezo ononya. I-Vitam Horm. 2011; 86: 379-99.

Lehouck A et, al. Amanani aphezulu ka vithamini D ukunciphisa ukukhushulwa kwezifo ezithathelwanayo zomshoshaphansi: ukuhlolwa okungahleliwe. U-Ann Intern Med. 2012 Jan 17; 156 (2): 105-14.

Lange NE et. al. Ukutholakala kwe-vitamin d, ukubhema, nokuphazamisa esifundweni sokuguga okujwayelekile. Am J Respir Crit Care Med. 2012 Okthoba 1; 186 (7): 616-21. i-doi: 10.1164 / rccm.201110-1868OC. I-Epub 2012 Jul 19.